To identify the molecular mechanism involved in this effect, we studied the influences of PhIP and then myricetin co-supplementation with PhIP on the gene expression levels of P53, a tumour-suppressor multi-functional gene and ATR kinase mRNA in lymphocytes. This evidence concerns the gene TP53 and neoplasm.